Welcome to our dedicated page for Wearable Devices Ltd. SEC filings (Ticker: WLDSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. SEC filings document the company’s foreign private issuer disclosures, business updates, and capital structure for its Nasdaq-listed ordinary shares and tradable warrants. Form 6-K reports include financial results, Mudra product and commercialization updates, equity financing activity, and material-event disclosures tied to its AI-powered touchless sensing wearables business.
The filing record also covers security-structure matters such as reverse share split disclosures, warrant adjustments, Nasdaq listing compliance, shareholder voting matters, and authorized share capital. Governance and compensation-related filings include updates to the company’s 2024 Global Equity Incentive Plan and incorporation of Form 6-K reports into Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. (WLDS) reported first‑half 2026 results showing small but growing sales alongside significantly higher investment spending. Revenue for the six months ended June 30, 2026 rose to $350 thousand, up about 19% from $294 thousand a year earlier, mainly from B2C sales of the Mudra Band and Mudra Link.
The company’s operating loss widened to $5.9 million and net loss to $5.5 million, up 48.6% year over year, driven by higher research and development, sales and marketing, and general and administrative expenses, including increased headcount and share‑based compensation. Cash used in operating activities was $4.2 million in the half.
WLDS remains at an early revenue stage but is well capitalized, with $18.8 million in cash and short‑term deposits and $18.6 million of shareholders’ equity as of June 30, 2026, after a series of equity raises and warrant inducement transactions. Management states existing cash is expected to fund operations through mid‑2028, and the board and management believe cash is sufficient for at least one year from approval of the financial statements. A side letter with J.B.D Innovation Ltd. provides a contingent $12 million convertible debt financing commitment if future liquidity needs arise. The company also discloses recent activist‑driven board changes and notes that regional geopolitical tensions have, as of August 24, 2026, had no material impact on operations.
Wearable Devices Ltd. (WLDS) disclosed that Vardi Avichy Nisan, a director of the company, filed an initial statement of beneficial ownership on Form 3. The filing lists no reportable transactions or holdings in the non-derivative or derivative securities tables as of the reporting date.
Wearable Devices Ltd. (WLDS) reports that Adler Oz, a director of the company, has filed an initial statement of beneficial ownership on Form 3. The filing lists no equity transactions, derivative positions, or reportable holdings for Adler Oz at this time.
Wearable Devices Ltd. (WLDS) reported that Revach Hila Kiron is a director and filed an initial statement of beneficial ownership on Form 3. The filing lists no equity holdings and no reportable transactions or derivative positions for this reporting person as of the filing date.
Wearable Devices Ltd. (WLDS) reported that Kabazo Gabriel is a director of the company in an initial beneficial ownership statement. This Form 3 filing does not list any equity holdings or report any transactions or derivative positions for the reporting person.
Wearable Devices Ltd. (WLDS), an Israel-incorporated biotechnology/health care technology company, reported a completed exempt securities offering under Rule 506(b) of Regulation D. The company sold securities for aggregate gross proceeds of $3,284,924 USD, with no remaining amount to be sold. The offering involved equity, warrants or other rights to acquire securities, and the securities issuable upon exercise of those rights. The company notes that the total amount sold excludes any additional proceeds that may be received if the warrants are exercised in the future. A.G.P./Alliance Global Partners is identified in connection with a 7.0% cash fee and 1.0% management fee as placement agent compensation.
Armistice Capital, LLC and Steven Boyd report beneficial ownership of 167,513 Ordinary Shares of Wearable Devices Ltd., representing 4.99% of the class. These shares are held by Armistice Capital Master Fund Ltd., for which Armistice Capital is investment manager and exercises voting and investment power under an Investment Management Agreement.
Armistice Capital and Steven Boyd may be deemed to share voting and dispositive power over all 167,513 shares, while the Master Fund has the right to receive dividends and sale proceeds. The filing confirms ownership of 5 percent or less of the issuer’s outstanding Ordinary Shares.
Wearable Devices Ltd. disclosed that J.B.D Innovation Ltd., Nissim Daniel, Victor Tshuva & Co. – Law Offices, and Victor Tshuva have sold all of their Ordinary Shares and no longer beneficially own any stake in the company. As of August 11, 2026, each reporting person holds 0 Ordinary Shares, representing 0% of the outstanding class, with no voting or dispositive power and no pecuniary interest.
On August 10, 2026, the group sold an aggregate 258,126 Ordinary Shares in open-market transactions, and on August 11, 2026, a further 123,235 shares, fully exiting their position and ceasing to be beneficial owners of 5% or more of the company’s Ordinary Shares.
Wearable Devices Ltd. and reporting holders J.B.D Innovation Ltd., Nissim Daniel, Victor Tshuva & Co. – Law Offices, and Victor Tshuva amended their Schedule 13D to reflect a new cooperation arrangement and updated ownership. The group has shared voting power over 381,361 ordinary shares, representing 15.50% of Wearable Devices’ outstanding 2,459,741 ordinary shares.
Under an August 7, 2026 Cooperation Agreement, two existing directors will resign and four new directors will be appointed, resulting in a seven‑member board. The parties’ court proceedings relating to a previously announced private placement were dismissed on August 10, 2026 with no order as to costs, and the demand for a special shareholder meeting was withdrawn. For two years, the reporting persons and their affiliates agreed not to seek to change or influence the company’s governance or management beyond what the agreement permits.
In a related Side Letter, J.B.D Innovation Ltd. committed, for 24 months, to provide the company with not less than $12.0 million in convertible debt financing if the board determines the company lacks sufficient resources to fund operations for the following 24 months.
Wearable Devices Ltd., an AI-powered touchless sensing wearables company, reports that the U.S. Patent and Trademark Office has granted a new continuation patent in its foundational “Gesture and Voice-Controlled Interface Device” family. The patent covers technologies that authenticate users based on combined gesture data and unique biological signals.
The granted claims describe a gesture interface device that integrates gesture sensors with biopotential sensors to record neural signals, then uses a processor to analyze gestures against a personalized gesture signature and build a gesture metric space. This supports accurate user verification and may enable use cases such as secure payments, user detection, and authorization of sensitive actions, enhancing the company’s hybrid voice-and-gesture control platform and broader neural input IP strategy.